Neuropathology of Parkinson disease

被引:412
作者
Dickson, Dennis W. [1 ]
机构
[1] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA
关键词
Parkinson disease; Neuropathology; alpha-Synuclein; Lewy body; ALPHA-SYNUCLEIN PATHOLOGY; PROGRESSIVE SUPRANUCLEAR PALSY; MULTIPLE SYSTEM ATROPHY; LEWY BODIES; DEGENERATION; DIAGNOSIS; DEMENTIA; BRAIN; INCLUSIONS; MANAGEMENT;
D O I
10.1016/j.parkreldis.2017.07.033
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Parkinson's disease (PD) is characterized by bradykinesia, rigidity, postural instability and tremor. Several pathologic processes can produce this syndrome, but neurodegeneration accompanied by neuronal inclusions composed of alpha-synuclein (Lewy bodies) is considered the typical pathologic correlate of PD. Methods: The neuropathologic features of PD are reviewed based upon personal experience and review of the literature. Molecular pathology of PD is summarized from cell biological and animal studies. Results: The pathologic feature that correlates with signs and symptoms of PD is neuronal loss in the substantia nigra with dopaminergic denervation of the striatum. Neuronal degeneration in the substantia nigra preferentially affects the ventrolateral cell group that projects to posterolateral putamen and is accompanied by formation of Lewy bodies composed of aggregated alpha-synuclein. Some patients with PD are found at autopsy to have other pathologic processes, such as multiple system atrophy, progressive supranuclear palsy and cerebrovascular disease (vascular Parkinsonism). The peripheral autonomic nervous system is also affected. The triggering event in PD is unknown, but recent studies suggest a role for loss of nuclear membrane integrity. Once alpha-synuclein aggregates forms, evidence supports cell-to-cell propagation. Conclusion: PD is a multisystem synucleinopathy caused by poorly characterized genetic and environmental factors that produces degeneration in selectively vulnerable neuronal populations. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:S30 / S33
页数:4
相关论文
共 30 条
[1]   Stages in the development of Parkinson's disease-related pathology [J].
Braak, H ;
Ghebremedhin, E ;
Rüb, U ;
Bratzke, H ;
Del Tredici, K .
CELL AND TISSUE RESEARCH, 2004, 318 (01) :121-134
[2]   α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro [J].
Burre, Jacqueline ;
Sharma, Manu ;
Tsetsenis, Theodoros ;
Buchman, Vladimir ;
Etherton, Mark R. ;
Suedhof, Thomas C. .
SCIENCE, 2010, 329 (5999) :1663-1667
[3]   Expanding the spectrum of neuronal pathology in multiple system atrophy [J].
Cykowski, Matthew D. ;
Coon, Elizabeth A. ;
Powell, Suzanne Z. ;
Jenkins, Sarah M. ;
Benarroch, Eduardo E. ;
Low, Phillip A. ;
Schmeichel, Ann M. ;
Parisi, Joseph E. .
BRAIN, 2015, 138 :2293-2309
[4]   The substantia nigra of the human brain - II. Patterns of loss of dopamine-containing neurons in Parkinson's disease [J].
Damier, P ;
Hirsch, EC ;
Agid, Y ;
Graybiel, AM .
BRAIN, 1999, 122 :1437-1448
[5]   Exosomal cell-to-cell transmission of alpha synuclein oligomers [J].
Danzer, Karin M. ;
Kranich, Lisa R. ;
Ruf, Wolfgang P. ;
Cagsal-Getkin, Ozge ;
Winslow, Ashley R. ;
Zhu, Liya ;
Vanderburg, Charles R. ;
McLean, Pamela J. .
MOLECULAR NEURODEGENERATION, 2012, 7
[6]  
Dickson DW, 2009, LANCET NEUROL, V8, P1150, DOI 10.1016/S1474-4422(09)70238-8
[7]   α-Synuclein and the Lewy body disorders [J].
Dickson, DW .
CURRENT OPINION IN NEUROLOGY, 2001, 14 (04) :423-432
[8]  
Fujishiro Hiroshige, 2013, Am J Neurodegener Dis, V2, P266
[9]   α-synuclein pathology in Parkinson's and Alzheimer's disease brain:: incidence and topographic distribution -: a pilot study [J].
Jellinger, KA .
ACTA NEUROPATHOLOGICA, 2003, 106 (03) :191-201
[10]   Histones facilitate α-synuclein aggregation during neuronal apoptosis [J].
Jiang, Peizhou ;
Gan, Ming ;
Yen, Shu-Hui ;
McLean, Pamela J. ;
Dickson, Dennis W. .
ACTA NEUROPATHOLOGICA, 2017, 133 (04) :547-558